Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Whether a Minimal Volume Could Predict Fluid Responsiveness Using Thermodilution by PAC in Septic Shock Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04515511
Recruitment Status : Recruiting
First Posted : August 17, 2020
Last Update Posted : September 3, 2020
Sponsor:
Information provided by (Responsible Party):
Peking Union Medical College Hospital

Brief Summary:
Assessment of fluid responsiveness (FR) is to detect whether patient could benefit from fluid therapy. Mini fluid challenge has been widely used in clinical practice to prevent patients from volume overload. In clinical practice, 100 mL or 250 mL have been used most frequently and FR was defined as an increase in CO greater than 10% as much as the changes in CO after infusion of 500 mL. While using a half of volume infusion and assessed by the traditional standard of FR, this might misclassify more patients as nonresponders. In that it is imperative to test the predictive ability of mini fluid and find out the threshold of cutoff value. Meanwhile, in almost mini-FC, cardiac output were measured by echocardiography(VTi) and pulse contour,None of the studies conducted cardiac output (CO)measurement by gold standard method of thermodilution by pulmonary artery catheter (PAC). The correlation between new generated CO measurements and PAC varies in different studies as well. It is imperative to investigate the reliability of mini-FC to predicting fluid responsiveness(FR).The investigator's study is to detect the predictive minimal volume using thermodilution by PAC in septic shock patient.

Condition or disease Intervention/treatment Phase
Septic Shock Hemodynamic Instability Fluid Therapy Other: 4% gelatin Not Applicable

Detailed Description:
Fluid therapy is the cornerstone of septic resuscitation. In recent decade, a restrictive fluid strategy has been applied to shock resuscitation for fewer complications and shorter hospital stays compared with a liberal fluid strategy. Therefore, it is a reasonable step to assess the patient's response to fluid infusion to avoid excessive fluid administration.Mini-fluid challenge allows the selection of fluid responders by inducible changes of hemodynamic parameters after changing the preload gaining popularity. The mini fluid challenge was firstly described by Muller et al. in 2011. They found an infusion of 100 mL colloid over 1 minute and the assessment by cardiac output using velocity time integral (VTi) at the aortic outflow tract could predict fluid responsiveness (FR). Since then, a total of seven investigations have been published. Although a mini-fluid challenge may help the decision-making process of fluid management, the investigation results differed from each other, especially in minimal volume and cut off value of hemodynamic parameters change. Meanwhile, we noticed that when measuring CO, the method of thermodilution by pulmonary artery catheter (PAC), which is the gold standard of CO measurement, was not used in these studies. Furthermore, the majority participants of the studies were perioperative patients in a stable hemodynamic state.Therefore, there are two question needed to be answered:what is the minimal infusion volume in effectively predicting fluid responsiveness, and whether mini-volume can perform a real change in septic shock patients. Thus, it is necessary to explore the minimal volume in fluid challenge by PAC and test its reliability in detecting responders (R) and nonresponders (NR).

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Medical Intensive Care Unit of PUMCH
Actual Study Start Date : July 1, 2019
Actual Primary Completion Date : August 1, 2020
Estimated Study Completion Date : September 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Shock
Drug Information available for: Gelatin

Arm Intervention/treatment
Experimental: standard care
ICU septic shock patients with refractory hypotension with indwelling pulmonary artery catheter received five sequential intravenous boluses of 100 mL 4% gelatin. Cardiac output measured by thermodilution of PAC before fluid challenge (baseline) and three minutes after each bolus. Fluid responsiveness (FR) was defined as an increase in CO greater than 10% after 500 mL fluid infusion. The smallest volume which can perform an effective fluid challenge was analyzed.
Other: 4% gelatin
Pulmonary artery catheter insertion is prepared before fluid challenge. Baseline hemodynamic value and each time after 5 sequential intravenous boluses of 100 mL colloid are recorded.
Other Name: Pulmonary artery catheter




Primary Outcome Measures :
  1. Cardiac output [ Time Frame: Baseline and immediately after each bolus of 100 mL colloid, average 3 minutes ]
    Cardiac output measured by therm-dilution of pulmonary artery catheter. An increase in cardiac output(CO) greater than 10% after a volume expansion of 500 mL is defined as fluid responsiveness(FR).


Secondary Outcome Measures :
  1. Oxygen saturation [ Time Frame: Baseline and immediately after each bolus of 100 mL colloid, average 3 minutes ]
    Oxygen saturation can be obtained directly from blood gas include which reflects extraction of oxygen and assess whether CO is sufficient enough to meet patient's enough.

  2. Carbon dioxide partial pressure [ Time Frame: Baseline and immediately after each bolus of 100 mL colloid, average 3 minutes ]
    PCO2 can be obtained directly from blood gas. It is considered as alternative markers of tissue hypoperfusion and attempted to be used to guide treatment for shock.

  3. Hemoglobin [ Time Frame: Baseline and immediately after each bolus of 100 mL colloid, average 3 minutes ]
    Hemoglobin will be diluted during fluid challenge and it is also an important index to guide fluid resuscitation by improving extraction of oxygen and optimizing oxygen delivery.

  4. Heart rate [ Time Frame: Baseline and immediately after each bolus of 100 mL colloid, average 1 minutes ]
    Heart rate is monitored to assess the effect of the fluid challenge

  5. Mean arterial pressure [ Time Frame: Baseline and immediately after each bolus of 100 mL colloid, average 1 minutes ]
    Mean arterial pressure is monitored to assess the effect of the fluid challenge

  6. Central venous pressure [ Time Frame: Baseline and immediately after each bolus of 100 mL colloid, average 1 minutes ]
    Central venous pressure is monitored to assess the preload status and effect of the fluid challenge



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients diagnosis of septic shock and is required fluid challenge in the presence of invasive hemodynamic monitoring.
  • Patients with hypotension (SBP <90 mmHg or MAP <65 mmHg)
  • Patients with evidences of tissue hypoperfusion (including but not limited to oliguria, skin mottling, altered mental status, cool peripheries, hyperlactatemia, et al).

Exclusion Criteria:

  • Age less than 18yrs or greater than 80yrs
  • Shock is diagnosed with other types of shock
  • Known allergy to colloid fluids
  • Pregnancy
  • Recent participation in another biomedical study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04515511


Contacts
Layout table for location contacts
Contact: Li Weng, Professor +8618600017819 wengli@gmail.com
Contact: Du Bin, Professor +8615601348897 dubin98@gmail.com

Locations
Layout table for location information
China, Beijing
Li Weng Recruiting
Beijing, Beijing, China, 100102
Contact: Li Weng, professor    15601348897    wengli@gmail.com   
Contact: Bin Du, professor    +8618600017819    dubin98@gmail.com   
Sponsors and Collaborators
Peking Union Medical College Hospital
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Peking Union Medical College Hospital
ClinicalTrials.gov Identifier: NCT04515511    
Other Study ID Numbers: PUMCH fc
First Posted: August 17, 2020    Key Record Dates
Last Update Posted: September 3, 2020
Last Verified: August 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: In our department, we has done a serial clinical studies of fluid challenge, we will do retrospective study first.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Peking Union Medical College Hospital:
Sepsis/Septic shock
Hemodynamic monitor
Fluid challenge
Cardiac output
Pulmonary artery catheter
Thermodilution
Additional relevant MeSH terms:
Layout table for MeSH terms
Shock, Septic
Shock
Pathologic Processes
Sepsis
Infections
Systemic Inflammatory Response Syndrome
Inflammation